China SXT Pharmaceuticals, Inc.
SXTC
$1.47
-$0.03-2.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.62% | 114.46% | 140.99% | 113.43% | 47.79% |
| Total Depreciation and Amortization | -59.45% | -43.66% | -30.45% | -24.53% | -18.78% |
| Total Amortization of Deferred Charges | 77.87% | 30.14% | -28.89% | -19.43% | -12.75% |
| Total Other Non-Cash Items | 25.66% | -146.26% | -161.31% | -139.83% | -72.59% |
| Change in Net Operating Assets | -154.66% | -318.96% | -197.24% | -162.94% | -126.96% |
| Cash from Operations | -21.65% | -147.70% | -2,333.09% | -2,313.33% | -2,286.14% |
| Capital Expenditure | 71.43% | 84.38% | 86.17% | 88.47% | 90.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -73.46% | -25.81% | -38.70% | -42.81% |
| Cash from Investing | 140.91% | 2,082.14% | 248.13% | 266.97% | 316.39% |
| Total Debt Issued | 413.79% | 190.96% | 110.68% | 25.23% | -62.86% |
| Total Debt Repaid | 52.19% | -272.77% | -86.31% | -551.95% | -40.62% |
| Issuance of Common Stock | -- | 25.75% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.46% | 42.24% | 58.78% | 66.60% | 74.43% |
| Cash from Financing | 420.04% | 152.34% | -4.97% | -48.36% | -189.22% |
| Foreign Exchange rate Adjustments | 91.48% | 133.57% | 168.50% | 93.22% | 27.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 214.38% | 310.30% | -16.93% | -82.92% | -394.15% |